Insiders · LYRA

Robert E. Richard

Officer at Lyra Therapeutics, Inc. (LYRA)

Robert E. Richard has filed 3 insider reports with the SEC since February 2021, as officer at Lyra Therapeutics, Inc. (LYRA). The latest filing, on February 2, 2023, reports grant or award at Lyra Therapeutics, Inc. (LYRA).

Filings
3
Companies
1
Bought on market
None
Sold on market
None

Companies where Robert E. Richard is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Lyra Therapeutics, Inc. logo
LYRA
Lyra Therapeutics, Inc.
Officer30,000$0.495Feb 2, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Robert E. Richard with

Other insiders at the same companies

Questions about Robert E. Richard

What is Robert E. Richard's role at Lyra Therapeutics, Inc.?
Robert E. Richard reports to the SEC as officer at Lyra Therapeutics, Inc. (LYRA), according to the latest filing on February 2, 2023.
How many shares does Robert E. Richard own?
After the latest filing that states it, Robert E. Richard directly owned 30,000 shares of Lyra Therapeutics, Inc. (LYRA). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Robert E. Richard bought or sold stock recently?
No open-market purchases or sales by Robert E. Richard are on file. The filings report grant or award.
How do I get alerts when Robert E. Richard files?
Follow Robert E. Richard on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Robert E. Richard (SEC CIK 0001816151). Totals count each trade once, skipping amendments whose original is on file, from Feb 10, 2021 on. View on SEC EDGAR · Get this as JSON